Does early coronary artery bypass surgery improve survival in non-ST acute myocardial infarction?

Victor Dayan1, Gerardo Soca, Gabriel Parma

  • 1Department of Cardiac Surgery and Cardiology, Cardiovascular Center, Hospital de Clinicas, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay. victor_dayan@hotmail.com

Insights

For non-ST myocardial infarction (NSTEMI) patients, coronary artery bypass graft (CABG) surgery after 6 hours is safe. Early CABG surgery in NSTEMI patients with high cardiac troponin I (cTnI) levels may increase risks; waiting for cTnI levels to decrease is advisable.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Evidence-Based Medicine

Background:

  • Optimal timing for coronary artery bypass graft (CABG) surgery after non-ST myocardial infarction (NSTEMI) remains unclear.
  • Current evidence is limited, with studies considering either surgical timing or myocardial damage extent.

Purpose of the Study:

  • To determine if early or late CABG surgery improves outcomes in stable NSTEMI patients.
  • To assess the impact of myocardial damage extent on CABG outcomes after NSTEMI.

Main Methods:

  • A systematic review of 459 articles identified seven Level 3 retrospective cohort studies.
  • Studies were categorized based on whether they assessed CABG outcomes using preoperative cardiac troponin I (cTnI) levels or solely timing after myocardial infarction.

Main Results:

  • Operative mortality for CABG after NSTEMI is higher when performed within 6 hours; mortality is similar at any timepoint after 6 hours.
  • Fewer postoperative complications are noted when CABG is performed after 48 hours, but no consensus exists on mortality differences between early (<48h) and late surgery.
  • Higher preoperative cTnI levels (>0.15 ng/ml) are associated with increased major adverse cardiovascular events (MACEs) and hospital mortality. Specifically, cTnI >0.72 ng/ml within 24 hours of symptoms correlates with worse outcomes.

Conclusions:

  • CABG surgery can be safely performed in NSTEMI patients after the initial 6 hours if cTnI levels are below 0.15 ng/ml.
  • For NSTEMI patients with higher cTnI levels, delaying surgery until levels decrease may reduce MACEs and hospital mortality.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...